Yahoo
HKSE - Delayed Quote HKD

Shenzhen Edge Medical Co., Ltd. (2675.HK)

30.700 -0.280 (-0.90%)
At close: October 30 at 4:08:06 PM GMT+8
Chart Range Bar
Loading chart for 2675.HK
  • Previous Close 30.980
  • Open 30.980
  • Bid 30.680 x --
  • Ask 30.900 x --
  • Day's Range 30.400 - 31.940
  • 52 Week Range 29.780 - 73.700
  • Volume 295,573
  • Avg. Volume 351,670
  • Market Cap (intraday) 11.898B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.050
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 57.16

Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS through a single small incision or natural orifice; Edge Cloud Telesurgery System; and Edge Bronchoscope Robot. The company also develops and manufactures instruments for Edge Multi-Port Endoscopic Surgical Robot and Single-Port Endoscopic Surgical Robot includes bipolar grasping forceps, bipolar separation forceps, needle holder forceps, monopolar scissors, monopolar electric hooks and other surgical tools. In addition, the company develops an non-invasive surgery by developing natural orifice surgical robots. It serves hospitals. The company sells its products through distributors. The company was formerly known as Shenzhen Jingfeng Medical Technology Co., Ltd. The company was incorporated in 2017 and is based in Shenzhen, China.

www.edgemed.cn

604

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2675.HK
47.97%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

2675.HK
47.97%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

2675.HK
47.97%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

2675.HK
47.97%
HANG SENG INDEX (^HSI)
8.21%

Analyst Insights

View More

Analyst Price Targets

51.84
57.16 Average
30.700 Current
60.54 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.00%

  • Return on Assets (ttm)

    0.38%

  • Return on Equity (ttm)

    -1.07%

  • Revenue (ttm)

    625.65M

  • Net Income Avi to Common (ttm)

    -18.77M

  • Diluted EPS (ttm)

    -0.050

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.86B

  • Total Debt/Equity (mrq)

    1.85%

  • Levered Free Cash Flow (ttm)

    -231.06M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: